View Post Prevalence of human immunodeficiency virus-1 drugresistant mutations among adults on first- and second-line antiretroviral therapy in a resourcelimited health facility in Busia County, Kenya. The Pan African Medical Journal, 37(311): 1-11. In by AHFDecember 15, 2020
View Post Discrepancies Between Self-Reported Adherence and a Biomarker of Adherence in Real-World Settings. Journal of Acquired Immune Deficiency Syndrome, 85(4): 454-457. In by AHFDecember 1, 2020
View Post Antiretroviral Therapy and Liver Disorders in the OPERA® Cohort. Therapeutic Advances in Drug Safety, 11: 1-12. In by AHFNovember 15, 2020
View Post Risk of Chronic Kidney Disease in People Living with HIV by Tenofovir Disoproxil Fumarate (TDF) Use and Baseline D:A:D Chronic Kidney Disease Risk Score. HIV Medicine, 22(5): 325-333. In by AHFNovember 1, 2020
View Post Assessing Bias Introduced in Estimated Glomerular Filtration Rate by the Inhibition of Creatinine Tubular Secretion from Common Antiretrovirals. Antiviral Therapy, 25(5): 287-292. In by AHFOctober 15, 2020
View Post Hepatitis B Infection in People Living with HIV Who Initiate Antiretroviral Therapy in Zimbabwe. Public Health Action, 10(3): 97-103. In by AHFSeptember 15, 2020
View Post Barriers to Hepatitis C Direct-acting Antiviral Therapy among HIV/HCV-Coinfected Persons. Journal of Gastroenterology and Hepatology, 1-8. In by AHFAugust 1, 2020
View Post Implementation of Antibody Rapid Diagnostic Testing Versus Real-Time Reverse Transcription-PCR Sample Pooling in the Screening of COVID-19: A Case of Different Testing Strategies in Africa. Clinical Science and Epidemiology, 5(4): 1-7. In by AHFJuly 15, 2020
View Post Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Chronic Kidney Disease Risk Score in HIV-Infected Patients in the USA. HIV Medicine, 21: 299-308. In by AHFMay 15, 2020
View Post Sexual and Gender-Based Violence and HIV in South Africa: An HIV Facility-Based Study. South African Medical Journal, 110(5): 377-381. In by AHFMay 1, 2020